
Meet us
Event | Date | Location | Presentation (local time) |
---|---|---|---|
ASH Annual Meeting
|
9. - 12. Dezember
|
San Diego
|
10. Dezember
|
Conferences & Presentations 2023
Event | Date | Location | Presentation (local time) | Link | Download |
---|---|---|---|---|---|
ASH Annual Meeting
|
9. - 12. Dezember
|
San Diego
|
10. Dezember
| ||
Deutsches Eigenkapitalforum
|
27. - 29. November
|
Frankfurt
|
28. November
| Download | |
Jefferies London Healthcare Conference
|
14. - 16. November
|
London
| |||
LSX Investival Showcase
|
13. November
|
London
| Download | ||
ACT American College of Toxicology
|
12. - 15. November
|
Orlando
| |||
BIO-Europe
|
6. - 8. November
|
Munich
| |||
ESMO Congress 2023
|
20. - 24. Oktober
|
Madrid
| |||
World ADC San Diego
|
16. - 19. Oktober
|
San Diego
|
17. Oktober
| Download | |
Festival of Biologics
|
10. - 12. Oktober
|
Basel
| |||
20th IMS Annual Meeting
|
27. - 30. September
|
Athens
| |||
EUROPIN Summer School on Drug Design
|
10. - 15. September
|
Vienna
| |||
ADC Toxicity Summit
|
25. - 27. Juli
|
Boston
|
27. Juli
| Download | |
Stifel European Healthcare Summit
|
28. - 30. Juni
|
Bordeaux
| |||
ICML International Conference on Malignant Lymphoma
|
13. - 17. Juni
|
Lugano
| |||
EHA2023 Hybrid Congress
|
8. - 11. Juni
|
Frankfurt
| |||
BIO International Convention
|
5. - 8. Juni
|
Boston
| |||
71th Conference on Mass Spectrometry and Applied Topics
|
4. - 8. Juni
|
Houston
| |||
PEGS Boston 2023
|
15. - 19. Mai
|
Boston
| |||
Kempen Life Sciences Conference
|
25. - 26. April
|
Amsterdam
| |||
AACR Annual Meeting
|
14. - 19. April
|
Orlando
| |||
Deutsche Biotechnologietage
|
28. - 29. März
|
Wiesbaden
|
28. März
| Download | |
BIO Europe Spring
|
20. - 22. März
|
Basel
| |||
Interview BioRN „M2M“
|
16. Februar
| ||||
Interview Effecten Spiegel
|
21. Januar
|
Ladenburg
| |||
German Equity Forum
|
28. - 30. November 2022
|
virtuelle Veranstaltung
|
28. Nov. / 10:30
| ||
Interview Börsenradio mit Dr. Jan Schmidt-Brand, CEO
| Download |
Presentations are archived information about Heidelberg Pharma AG and were current at the time they were published. Archived information may have been replaced by more recent information published by the company in more recent presentations, press releases or elsewhere. The presentations and recordings may contain forward-looking statements based on management's beliefs as of the date of publication. Actual developments may differ materially from the information contained in the publications due to various factors.